Expression profiling of V600E BRAF and RTK-activated cells upon MEK inhibition
Expression microarray · human · 36 samples
- What it is
- Expression microarrayGene activity read on a chip (the older technology that RNA-seq replaced).
- Organism
- Homo sapiens (human)
- Samples
- 36 samples: 36 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed expression table (series matrix) and the array files, from NCBI.
Direct links to NCBI, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need.
Whole study · RAW.tar
Everything the authors deposited as one archive (GSE10086_RAW.tar), including the raw array or instrument files. Can be large; the picker in step 2 takes just the samples you need.
What the files usually look like: For arrays the series matrix is normally the normalised expression table you want; the raw array files (CEL and similar) are in the RAW.tar.
Also filed as BioProject PRJNA108653. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 36 sample titles: 36 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM254931 MDA468-DMSO
- GSM254932 MDA468-901
- GSM254933 H1650-DMSO
- GSM254934 H1650-901
- GSM254935 A431-DMSO
- GSM254936 A431-901
- GSM254937 BT474-DMSO
- GSM254938 BT474-901
- GSM254939 SKBR3-DMSO
- GSM254940 SKBR3-901
- GSM254941 COLO205-DMSO
- GSM254942 COLO205-901
- GSM254943 HT29-DMSO
- GSM254944 HT29-901
- GSM254945 MALME3M-DMSO
- GSM254946 MALME3M-901
- GSM254947 SKMEL1-DMSO
- GSM254948 SKMEL1-901
- GSM254949 SKMEL5-DMSO
- GSM254950 SKMEL5-901
- GSM254951 SKMEL19-DMSO
- GSM254952 SKMEL19-901
- GSM254953 SKMEL28-DMSO
- GSM254954 SKMEL28-901
- GSM254955 B1-xeno-vehicle
- GSM254956 B4-xeno-vehicle
- GSM254957 M2-xeno-vehicle
- GSM254958 M5-xeno-vehicle
- GSM254959 B5-xeno-901
- GSM254960 B7-xeno-901
- GSM254961 M7-xeno-901
- GSM254962 M10-xeno-901
- GSM254963 SKMEL28-901-timecourse-0HRS
- GSM254964 SKMEL28-901-timecourse-2HRS
- GSM254965 SKMEL28-901-timecourse-8HRS
- GSM254966 SKMEL28-901-timecourse-24HRS
- GSE298507 Inhibition of BCL2 family proteins overcomes acquired resistance to standard of care BRAF and MEK inhibitors in a subset of BRAFV600E-mutant melanomas 58 samples shares v600e, braf, mek, inhibition
- GSE255541 Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibition 45 samples shares v600e, braf, mek, inhibition
- GSE254366 Epigenome reprogramming through H3K27 and H3K4 trimethylation as a resistance mechanism to DNA methylation inhibition in BRAFV600E-mutated CRC. 36 samples shares v600e, braf, inhibition
- GSE303418 Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors 36 samples shares braf, mek, inhibition
- GSE271504 Effect of BRAF and MEK inhibition in KRAS mutant NSCLC cell line NCI-H358 32 samples shares braf, mek, inhibition
- GSE254365 Epigenome reprogramming through H3K27 and H3K4 trimethylation as a resistance mechanism to DNA methylation inhibition in BRAFV600E-mutated CRC. [ChIP-Seq] 30 samples shares v600e, braf, inhibition
- GSE254604 Epigenome reprogramming through H3K27 and H3K4 trimethylation as a resistance mechanism to DNA methylation inhibition in BRAFV600E-mutated CRC [ATAC-seq] 12 samples shares v600e, braf, inhibition
- GSE308451 CDK4/6 and SHP2 mediate BRAF/MEK inhibitor resistance in Class 2 and 3 BRAF mutant cancers 90 samples shares braf, mek
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.